NervGen Pharma (NGEN) Live Share Price, Invest From India

NervGen Pharma Stock Performance

as on September 4, 2026 at 2:07 am IST

Day's Low
Day's High
$2.27
Day's Price Range
$2.36
$2.31
1.73%
Downside
2.16%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$2.31
100.00%
Downside
-100.00%
Upside

NervGen Pharma share price movements today

Previous Close: $2.33
Open: $2.34
Volume: 163.8K
Market Cap: $237.6M
Day's Low - High: $2.27 - $2.36

NervGen Pharma Historical Returns

1 Month Return: + 43.21 %
3 Month Return: + 16 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

NervGen Pharma Stock Fundamentals & Key Indicators

Check NervGen Pharma market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$237.6M

EPS (TTM)

-0.8457

Dividend Yield

0.00%

PE Ratio (TTM)

-8.41

Industry PE ratio

-1.4626335877862595

PEG Ratio

0.11770645391384338

Return On Equity TTM

-17536.81%

NervGen Pharma Stock Valuation

Track how NervGen Pharma P/E has moved over time to understand its valuation trends.

NervGen Pharma in the last 5 years

Overview
Trends

Lowest (-17.06x)

March 31, 2025

Today (-12.60x)

March 31, 2026

Industry (-1.46x)

March 31, 2026

Highest (-4.65x)

December 31, 2022

LowHigh

Today’s Price to Earnings Ratio: -12.60x

NervGen Pharma vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of NervGen Pharma with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
NervGen Pharma	StrongBuy	$237.6M	NA	-8.41	0.00%	NA
Revolution Medicines	BUY	$44.6B	614.61%	NA	0.00%	NA
Vertex Pharmaceuticals	BUY	$137.9B	174.9%	31.92	86.04%	NA
Moderna	BUY	$61.6B	-61.21%	-7.98	-12.57%	NA
Regeneron	BUY	$82.3B	21.91%	19.9	84.86%	0.44%

Analyst Recommendation on NervGen Pharma Stock

Based on 3 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 3 analysts, 100% of analysts recommend a 'BUY' rating for NervGen Pharma. Average target price of $12.5

Indian Investors' Interest in NervGen Pharma Stock

Search interest for NervGen Pharma Stock has decreased by -68% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 4, 2026 to September 3, 2026

Change:-68% versus previous 30 day period

NervGen Pharma Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025	Mar 2026	Jun 2026
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-4	-3	-4	-	-7	-6	-6	-6	-7	-12
EBITDA	-4	-4	-2	-7	-5	-3	-9	-4	-1	-12
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-4	-4	-2	-7	-5	-3	-9	-4	-1	-29
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-4	-4	-2	-7	-5	-3	-9	-4	-1	-29
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

NervGen Pharma Annual Profit & Loss

All numbers in Millions USD

	Dec 2017	Mar 2020	Mar 2021	Dec 2021	Dec 2022	Mar 2024	Mar 2025	Mar 2026
Total Revenue	-	-	-	-	-	-	-	-
Gross Profit	-	0	0	0	0	0	0	-
Operating Income	0	-10	-11	-12	-22	-17	-24	-25
EBITDA	0	-9	-11	-12	-19	-22	-23	-5
Interest Expense	-	-	-	-	0	-	-	-
Depreciation	0	0	0	0	0	0	0	0
Income Before Tax	0	-10	-11	-12	-20	-22	-23	-44
Income Tax Expense	-	-	-	-	-	-	-	-
Net Income	0	-10	-11	-12	-20	-22	-23	-44
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

NervGen Pharma Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025	Mar 2026	Jun 2026
Net Income	-4	-4	-2	-7	-5	-3	-9	-4	-1	-29
Operating Cash Flow	-1	-1	-3	-4	-5	-4	-3	-5	-8	-5
Investing Cash Flow	0	0	-	0	0	0	0	0	0	0
Financing Cash Flow	0	0	22	0	0	1	4	0	2	80
Change in Cash	-1	-1	18	-4	-5	-2	1	-4	-5	70

NervGen Pharma Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Mar 2020	Mar 2021	Dec 2021	Dec 2022	Mar 2024	Mar 2025	Mar 2026
Net Income	0	-1	-10	-11	-12	-20	-22	-23	-44
Operating Cash Flow	-	-1	-8	-6	-8	-17	-11	-16	-19
Investing Cash Flow	-	0	-	0	0	0	0	0	0
Financing Cash Flow	-	3	10	7	19	22	0	22	23
Change in Cash	-	2	1	1	11	4	-10	4	4

Global Institutional Holdings in NervGen Pharma

Funds	Holdings
Michael Rockefeller	0.23%

Insights on NervGen Pharma

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 1 month, NGEN stock has moved up by 42.1%

About NervGen Pharma

NervGen Pharma Corp., a biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease. The company's lead product candidate is NVG-291 that is in Phase 1b/2a clinical trial for the treatment of spinal cord injuries (SCI), stroke, multiple sclerosis, and Alzheimer's disease; and NVG-300, which is in a preclinical model of ischemic stroke, amyotrophic lateral sclerosis, and confirmatory SCI study. NervGen Pharma Corp. has a licensing agreement with Case Western Reserve University to develop and commercialize a patented technology with therapeutic potential for spinal cord injury and other conditions associated with nerve damage. NervGen Pharma Corp. was incorporated in 2017 and is headquartered in Vancouver, Canada.

Organisation	NervGen Pharma
Headquarters	112-970 Burrard Street, Vancouver, BC, Canada, V6Z 2R4
Industry	Biotechnology
CEO	Dr. Adam H. Rogers M.D.
E-voting on shares	Click here to vote

Key Management of NervGen Pharma

Name	Title
Dr. Keith A. Vendola M.B.A., M.D.	Chief Financial Officer
Ms. Shamim Ruff M.S.	Chief Regulatory Affairs Officer
Ms. Christine McSherry	Senior Vice President of Patient Advocacy & Clinical Affairs
Dr. Adam H. Rogers M.D.	President, CEO & Chairman
Dr. Harold Martin Punnett D.M.D.	Co-Founder & Independent Director
Dr. Randall E. Kaye M.D.	Chief Medical Advisor & Director

FAQs

What is NervGen Pharma share price today?

NervGen Pharma share price today is $2.31 as on September 3, 2026 at 8:37 pm IST. NervGen Pharma share today touched a day high of $2.36 and a low of $2.27.

What is the 52 week high and 52 week low for NervGen Pharma share?

NervGen Pharma share touched a 52 week high of $0.00 on January 1, 1970 and a 52 week low of $0.00 on January 1, 1970. NervGen Pharma stock price today i.e. September 3, 2026 at 8:37 pm IST is trending at $2.31,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is NervGen Pharma's market capitalisation today?

NervGen Pharma market capitalisation is $0.00T as on September 3, 2026 at 8:37 pm IST.

How to invest in NervGen Pharma Stock (NGEN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for NervGen Pharma on INDmoney app. Click on Buy button. You can invest as low as $1.5 in NervGen Pharma Shares that will get you 0.6494 shares as per NervGen Pharma share price of $2.31 per share as on September 3, 2026 at 8:37 pm IST.

What is the minimum amount required to buy NervGen Pharma Stock (NGEN) from India?

Indian investors can start investing in NervGen Pharma (NGEN) shares with as little as ₹94.475 or $1 (as of September 3, 2026 at 8:37 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹944.75 in NervGen Pharma stock (as per the Rupee-Dollar exchange rate as on September 3, 2026 at 8:37 pm IST). Based on NervGen Pharma share’s latest price of $2.31 as on September 3, 2026 at 8:37 pm IST, you will get 4.3290 shares of NervGen Pharma. Learn more about fractional shares .